US Broker Ratings

Integer Holdings Corporation (ITGR): Investor Outlook with a 24% Upside Potential

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity for individual investors. With a market capitalization of $4.19..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 28.69% Potential Upside

Waystar Holding Corp. (WAY), a prominent player in the healthcare information services industry, stands out with its innovative cloud-based software solutions tailored for healthcare payments. With a market capitalization of..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 24.72% Potential Upside

Universal Health Services, Inc. (UHS), a prominent player in the healthcare sector, stands out in the medical care facilities industry with a market capitalization of $11.76 billion. Headquartered in King..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Evaluating a 63.94% Potential Upside in the Medical Device Sector

Inspire Medical Systems, Inc. (NYSE: INSP), a prominent player in the healthcare sector, is drawing significant attention from the investor community. With a market capitalization of $3.84 billion, the company..

Koninklijke Philips N.V. (PHG) Stock Analysis: Unpacking the 32.20% Potential Upside

Investors with an eye on the healthcare sector may find Koninklijke Philips N.V. (NYSE: PHG) a noteworthy contender, especially given its significant potential upside of 32.20%. As a leading player..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 16% Upside Potential

For investors seeking opportunities in the healthcare sector, Merit Medical Systems, Inc. (NASDAQ: MMSI) stands out with a compelling mix of strong analyst ratings and significant upside potential. As a..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Insights on Healthcare Giant’s Moderate Growth and Investor Ratings

Bausch + Lomb Corporation (BLCO), a prominent player in the healthcare sector, is a company that many investors have their eyes on due to its substantial market presence and a..

Rhythm Pharmaceuticals, Inc. (RYTM): Investor Outlook on a Biotechnology Standout with 12 Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is carving a niche in the healthcare industry with its specialized focus on rare neuroendocrine diseases. As a commercial-stage biopharmaceutical entity, Rhythm Pharmaceuticals is making..

Genmab A/S (GMAB) Stock Analysis: 38.73% Potential Upside Fuels Investor Interest

Genmab A/S (NASDAQ: GMAB), a leading biotechnology company headquartered in Copenhagen, Denmark, is capturing investor attention with its promising outlook and a robust 38.73% potential upside. Operating in the dynamic..

ADMA Biologics Inc (ADMA) Stock Analysis: Unveiling a 59% Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, has captured the attention of investors with a compelling potential upside of 59.32%. Specializing in plasma-derived biologics, ADMA..

TG Therapeutics, Inc. (TGTX): Investor Outlook with an 11.10% Upside Potential in Biotechnology

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, continues to capture investor interest with its promising pipeline and strategic focus on B-cell mediated diseases. Headquartered in..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a Potential 24% Upside

For investors seeking exposure to the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents an intriguing opportunity. With a market cap of $14.92 billion, this healthcare titan operates within..

Glaukos Corporation (GKOS) Stock Analysis: Unveiling a 17.97% Potential Upside in the Medical Device Sector

Glaukos Corporation (NYSE: GKOS) is carving out a notable position within the healthcare sector, specifically in the medical devices industry. With a market capitalization of approximately $5.93 billion, this U.S.-based..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Revenue Growth Soars Amid Promising Drug Pipeline

Cytokinetics, Incorporated (NASDAQ: CYTK), a notable player in the biotechnology sector, has captured investor attention with its robust 89.10% revenue growth and a promising pipeline of muscle-targeted therapies. The company,..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Navigating a 7.34% Potential Upside in the Digital Healthcare Arena

iRhythm Technologies, Inc. (NASDAQ: IRTC) is making waves in the digital healthcare sector, capturing investor interest with its innovative solutions in ambulatory cardiac monitoring. Headquartered in San Francisco, the company..

Blueprint Medicines Corporation (BPMC) Stock Analysis: A Biotech with Potential Amidst Challenging Metrics

Blueprint Medicines Corporation (NASDAQ: BPMC), a prominent player in the biotechnology sector, is capturing investor attention with its robust pipeline of precision therapies targeting genomically defined cancers and blood disorders...

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 10.73% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, specializing in diagnostics and research, captures investor attention with its notable growth potential and solid financial footing. As..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 28.64% Potential Upside with Strong Buy Ratings

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector as a significant player in the specialty and generic drug manufacturing industry. With a robust market cap of $13.33..

Illumina, Inc. (ILMN) Stock Analysis: Evaluating Growth Potential Amidst Market Volatility

Illumina, Inc. (NASDAQ: ILMN), a prominent player in the healthcare sector specializing in diagnostics and research, is at a pivotal point as it navigates market fluctuations and investor expectations. With..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a 65% ROE Amidst Market Volatility

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector specializing in diagnostics and research, has captured investor attention with its impressive financial metrics, particularly a return on..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds